Unpredictable regulatory environment in emerging markets impacting global R&D
This article was originally published in Scrip
Executive Summary
Variable and unpredictable approval timelines in the current regulatory environment in emerging markets are bringing uncertainty to global drug development, manufacturing and commercialisation as these markets increasingly become an integral part of the industry's global R&D footprint.